HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$25.73
Day range
$24.90 - $25.86
Year range
$10.44 - $47.65
Market cap
2.06B USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.28M | -26.05% |
Net income | -32.23M | 34.14% |
Net profit margin | — | — |
Earnings per share | -0.40 | 59.18% |
EBITDA | -38.27M | 26.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 656.64M | 231.32% |
Total assets | 661.81M | 221.42% |
Total liabilities | 15.11M | 3.19% |
Total equity | 646.69M | — |
Shares outstanding | 82.40M | — |
Price to book | 3.24 | — |
Return on assets | -15.17% | — |
Return on capital | -15.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -32.23M | 34.14% |
Cash from operations | -37.89M | 43.32% |
Cash from investing | -103.49M | -223.84% |
Cash from financing | 96.70M | 107,345.56% |
Net change in cash | -44.68M | -365.66% |
Free cash flow | -25.63M | 47.60% |
About
Founded
2019
Website
Employees
76
